Legend Biotech Corp. (LEGN)
21.63
-0.67
(-3.00%)
USD |
NASDAQ |
Oct 30, 16:00
21.64
+0.01
(+0.05%)
After-Hours: 20:00
Legend Biotech Cash and Short Term Investments (Annual) : 948.60M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 948.60M |
| December 31, 2024 | 1.123B |
| December 31, 2023 | 1.309B |
| December 31, 2022 | 1.027B |
| December 31, 2021 | 883.84M |
| Date | Value |
|---|---|
| December 31, 2020 | 506.07M |
| December 31, 2019 | 159.18M |
| December 31, 2018 | 216.44M |
| December 31, 2017 | 2.115M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Gilead Sciences, Inc. | 9.613B |
| Ionis Pharmaceuticals, Inc. | 2.677B |
| Johnson & Johnson | 20.10B |
| Arbutus Biopharma Corp. | 91.47M |
| ACADIA Pharmaceuticals, Inc. | 819.69M |